Boston Scientific (Natick, Massachusetts) reported that it has signed an agreement to sell its fluid management and venous access businesses for $425 million in cash to private equity firm Avista Capital Partners, thereby, it said last month, completing its program for spinning off what it termed "non-stategic" assets.
Browse by Speciality Area